Publications by authors named "Tore Persson"

Claim this Profile
L
Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study.
Edeltraut Garbe, Fabian Hoti, Tania Schink, Kristian Svendsen, Haydar Al-Eid, Tore Persson

Int J Chron Obstruct Pulmon Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of methacholine provocation when assessing therapeutic equivalence between two inhalers in asthmatic patients.
Thomas Bengtsson, Jonas Román, Tore Persson

Contemp Clin Trials· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children.
Stanley A Cohen, Marina Aloi, Ramalingam Arumugam, Robert Baker, Kevin Bax, Tore Persson

Curr Med Res Opin· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methacholine challenge tests to demonstrate therapeutic equivalence of terbutaline sulfate via different Turbuhaler devices in patients with mild to moderate asthma: Appraisal of a four-way crossover design.
Leif Bjermer, Gail M Gauvreau, Dirkje S Postma, Paul M O'Byrne, Maarten van den Berge, Tore Persson

Pulm Pharmacol Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial.
Dennis M Jensen, Stefan Eklund, Tore Persson, Henrik Ahlbom, Robert Stuart

Am J Gastroenterol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of baseline characteristics on response to proton pump inhibitors in patients with peptic ulcer bleeding.
James Lau, Tore Lind, Tore Persson, Stefan Eklund

J Dig Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease.
Ekkehard Bayerdörffer, Marc-Andre Bigard, Werner Weiss, Fermín Mearin, Luis Rodrigo, Tore Persson

BMC Gastroenterol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study.
Alexander Eser, Jean-Frederic Colombel, Paul Rutgeerts, Severine Vermeire, Harald Vogelsang, Tore Persson

Inflamm Bowel Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial.
Lars Lundell, Jan Hatlebakk, Jean-Paul Galmiche, Stephen E Attwood, Christian Ell, Tore Persson

Curr Med Res Opin· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial.
Nigel W Flook, Paul Moayyedi, John Dent, Nicholas J Talley, Tore Persson

Am J Gastroenterol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index.
Kelvin Thia, William A Faubion, Edward V Loftus, Tore Persson, Anders Persson

Inflamm Bowel Dis· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma.
Tari Haahtela, Klaus Tamminen, Tuomo Kava, L Pekka Malmberg, Paula Rytilä, Tore Persson

J Allergy Clin Immunol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
Martyn R Partridge, Wolfgang Schuermann, Ola Beckman, Tore Persson, Tomasz Polanowski

Ther Adv Respir Dis· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms.
Nimish Vakil, Nicholas Talley, Sander Veldhuyzen van Zanten, Nigel Flook, Tore Persson

Clin Gastroenterol Hepatol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
Kelvin T Thia, William J Sandborn, James D Lewis, Edward V Loftus, Brian G Feagan, Tore Persson

Am J Gastroenterol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Why do "diet experts" deny science?].
Ralf Sundberg, Karl-E Arfors, Annika Dahlqvist, Christer Enkvist, Björn Hammarskjöld, Tore Persson

Lakartidningen· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis.
John R Kirwan, Sarah H Hickey, Roger Hällgren, Herman Mielants, Ewa Björck, Tore Persson

Arthritis Rheum· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of bronchial responsiveness measurements in young infants.
Lotte Loland, Frederik F Buchvald, Liselotte Brydensholt Halkjaer, Jacob Anhøj, Graham L Hall, Tore Persson

Chest· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.
Erik J Schoon, Simona Bollani, Peter R Mills, Eran Israeli, Dieter Felsenberg, Tore Persson

Clin Gastroenterol Hepatol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.
William J Tremaine, Stephen B Hanauer, Seymour Katz, Barry D Winston, Jeffrey G Levine, Tore Persson, Anders Persson

Am J Gastroenterol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.
Ole O Thomsen, Antoine Cortot, Derek Jewell, John P Wright, Trevor Winter, Tore Persson

Am J Gastroenterol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early treatment of stage II sarcoidosis improves 5-year pulmonary function.
Anne Pietinalho, Pentti Tukiainen, Tari Haahtela, Tore Persson, Olof Selroos

Chest· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis